Lucy Gilbert
Impact in
- Obstetrics and Gynecology top 0.2%
- Endometrial and Cervical Cancer Treatments
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Endometrial and Cervical Cancer Treatments 68
- Uterine Myomas and Treatments 5
-
- Ovarian cancer diagnosis and treatment 37
- Co-authors
- Ri‐Cheng Chian (5 shared papers)Seang Lin Tan (5 shared papers)Jack Y.J. Huang (4 shared papers)William M Buckett (3 shared papers)Hananel E. G. Holzer (3 shared papers)G. Stanimir (5 shared papers)Ana Oaknin (22 shared papers)Jocelyne Arseneau (13 shared papers)
- Journals
- Gynecologic Oncology (31 papers)International Journal of Gynecological Cancer (30 papers)Annals of Oncology (16 papers)The Lancet (8 papers)Journal of Clinical Oncology (7 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Lucy Gilbert
162 papers receiving 7.7k citations
Lucy Gilbert's Hit Papers
Peers
Comparison fields: 5 of 116
- Obstetrics and Gynecology 1.8k
- Reproductive Medicine 1.3k
- Oncology 2.4k
- Endocrinology, Diabetes and Metabolism 426
- Cancer Research 309
Countries citing papers authored by Lucy Gilbert
This map shows the geographic impact of Lucy Gilbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Gilbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Gilbert more than expected).
Fields of papers citing papers by Lucy Gilbert
This network shows the impact of papers produced by Lucy Gilbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Gilbert. The network helps show where Lucy Gilbert may publish in the future.
Co-authors
The 25 scholars most cited alongside Lucy Gilbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 178 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer Hit paper breakdown → | 2016 | 2026 |
| 2 | Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer Hit paper breakdown → | 2023 | 560 |
| 3 | 2020 | 284 | |
| 4 | Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study Hit paper breakdown → | 2022 | 241 |
| 5 | Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial Hit paper breakdown → | 2024 | 241 |
| 6 | Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial Hit paper breakdown → | 2023 | 238 |
| 7 | 2018 | 196 | |
| 8 | 2013 | 183 | |
| 9 | 2009 | 161 | |
| 10 | 2008 | 159 | |
| 11 | 2009 | 158 | |
| 12 | 2008 | 156 | |
| 13 | 2011 | 154 | |
| 14 | 2017 | 148 | |
| 15 | 2019 | 143 | |
| 16 | 2010 | 135 | |
| 17 | 2008 | 130 | |
| 18 | 2012 | 128 | |
| 19 | 2020 | 122 | |
| 20 | Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2024 | 108 |
About Lucy Gilbert
Lucy Gilbert is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Oncology, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 178 papers that have together received 8k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (68 papers), Ovarian cancer diagnosis and treatment (37 papers), Cancer Immunotherapy and Biomarkers (21 papers), PARP inhibition in cancer therapy (13 papers), Cervical Cancer and HPV Research (13 papers), Uterine Myomas and Treatments (5 papers), Menopause: Health Impacts and Treatments (5 papers) and Reproductive Biology and Fertility (5 papers). The work is most often cited by research in Obstetrics and Gynecology (1.8k citations), Reproductive Medicine (1.3k citations), Oncology (2.4k citations), Endocrinology, Diabetes and Metabolism (426 citations) and Cancer Research (309 citations). Lucy Gilbert has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Ri‐Cheng Chian, Seang Lin Tan, Jack Y.J. Huang, William M Buckett, Hananel E. G. Holzer, G. Stanimir, Ana Oaknin, Jocelyne Arseneau, Diane Michele Provencher and David M. O’Malley. Their work appears in journals such as Gynecologic Oncology, International Journal of Gynecological Cancer, Annals of Oncology, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.